Abstract AIMS With diminishing returns and common clinical failure rates from traditional preclinical animal-based drug discovery strategies, emphasis is being placed on alternative platforms, such as ex vivo approaches. Such approaches represent a departure both models more clinical-based strategies aim to address intra/inter-patient variability at an earlier stage of discovery. Additionally, ...

AIMS To characterize atomoxetine pharmacokinetics, explore the effect of the homozygous CYP2D6*10 genotype on atomoxetine pharmacokinetics and evaluate the tolerability of atomoxetine, in healthy Chinese subjects. METHODS Twenty-four subjects, all CYP2D6 extensive metabolizers (EM), were randomized to receive atomoxetine (40 mg qd for 3 days, then 80 mg qd for 7 days) or matching placebo (2 :...

Treatment for medulloblastoma carries significant risks, particularly in resource-constrained settings. We report a case of a Mexican infant with desmoplastic/nodular medulloblastoma. Given the nature of her tumor, we developed a tailored regimen following subtotal resection to avoid both radiation therapy and the high-dose cisplatin therapy offered at most centers in the United States. The pat...

Immunohistochemical studies were conducted in 20 cases of canine thyroid tumours. On histological grounds the tumours included four well-differentiated follicular and four well-differentiated medullary carcinomas. Four tumours were suspected to be of possible follicular origin but were poorly-differentiated or anaplastic (undifferentiated); similarly six tumours that were poorly-differentiated ...

nanotechnology is the engineering of functional systems at the molecular scale which may exert a revolutionary impact on cancer diagnosis and therapy. nanotechnology is being applied to cancer in two broad areas: i) the development of nanovectors such as nanoparticles which can be loaded with drugs or imaging agents and then targeted to tumours, and ii) high-throughput nanosensor devices for de...